Toll-like receptors - Novel targets in allergic airway disease (probiotics, friends and relatives)

European Journal of Pharmacology

Volumn 533, Issue 1-3, 2006, Pages 308-318

  Feleszko, Wojciech ^a   Jaworska, Joanna ^a,b   Hamelmann, Eckard ^b  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Allergy; Asthma; Bacterial extract; CpG motif; Hygiene hypothesis; Lipopolysaccharide; Mycobacteria; Probiotics; T helper cell; T regulatory cells; Toll like receptors

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL VACCINE; BCG VACCINE; CORTICOSTEROID; CPG OLIGODEOXYNUCLEOTIDE; GLUCOCORTICOID; IMIDAZOQUINOLINE DERIVATIVE; IMIQUIMOD; IMMUNOGLOBULIN E; INACTIVATED VACCINE; LIPID A; LIPOPOLYSACCHARIDE; OLIGONUCLEOTIDE; PHOSPHORYL LIPID A; PROBIOTIC AGENT; RECEPTOR BLOCKING AGENT; RESIQUIMOD; SYNTHETIC PEPTIDE; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 10; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 4 BLOCKING AGENT; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG;

ALLERGIC CONJUNCTIVITIS; ALLERGIC DISEASE; ALLERGIC RHINITIS; ANTIGEN PRESENTATION; ASTHMA; ATOPIC DERMATITIS; ATOPY; CLINICAL TRIAL; CONDYLOMA; DRUG TARGETING; GENITAL HERPES; HUMAN; IMMUNOMODULATION; IMMUNOREGULATION; IMMUNOSTIMULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; REGULATORY T LYMPHOCYTE; RESPIRATORY TRACT ALLERGY; REVIEW; TH1 CELL; TH2 CELL; TOXICITY;

ANIMALS; ASTHMA; BACTERIAL VACCINES; CLINICAL TRIALS; CPG ISLANDS; DISEASE MODELS, ANIMAL; HUMANS; IMMUNOLOGIC FACTORS; IMMUNOTHERAPY; LIPOPOLYSACCHARIDES; PROBIOTICS; TOLL-LIKE RECEPTORS;

EID: 33644761802     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.12.062     Document Type: Review

References (98)

1. I. Adlerberth, B. Carlsson, P. de Man, F. Jalil, S.R. Khan, P. Larsson, L. Mellander, C. Svanborg, A.E. Wold, and L.A. Hanson Intestinal colonization with Enterobacteriaceae in Pakistani and Swedish hospital-delivered infants Acta Paediatr. Scand. 80 1991 602 610
2. S. Agrawal, A. Agrawal, B. Doughty, A. Gerwitz, J. Blenis, T. Van Dyke, and B. Pulendran Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos J. Immunol. 171 2003 4984 4989
3. S. Akira, and K. Takeda Toll-like receptor signalling Nat. Rev. Immunol. 4 2004 499 511
4. S. Akira, K. Takeda, and T. Kaisho Toll-like receptors: critical proteins linking innate and acquired immunity Nat. Immunol. 2 2001 675 680
5. J.S. Alm, G. Lilja, G. Pershagen, and A. Scheynius Early BCG vaccination and development of atopy Lancet 350 1997 400 403
6. J.S. Alm, J. Swartz, G. Lilja, A. Scheynius, and G. Pershagen Atopy in children of families with an anthroposophic lifestyle Lancet 353 1999 1485 1488
7. P.D. Arkwright, and T.J. David Effect of Mycobacterium vaccae on atopic dermatitis in children of different ages Br. J. Dermatol. 149 2003 1029 1034
8. J.F. Bach The effect of infections on susceptibility to autoimmune and allergic diseases N. Engl. J. Med. 347 2002 911 920
9. M. Baldini, I.C. Lohman, M. Halonen, R.P. Erickson, P.G. Holt, and F.D. Martinez A Polymorphism in the 5′ flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E Am. J. Respir. Cell Mol. Biol. 20 1999 976 983
10. S. Bauer, C.J. Kirschning, H. Hacker, V. Redecke, S. Hausmann, S. Akira, H. Wagner, and G.B. Lipford Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition Proc. Natl. Acad. Sci. U. S. A. 98 2001 9237 9242
11. B. Berman Imiquimod: a new immune response modifier for the treatment of external genital warts and other diseases in dermatology Int. J. Dermatol. 41 Suppl 1 2002 7 11
12. J. Boasen, D. Chisholm, L. Lebet, S. Akira, and A.A. Horner House dust extracts elicit Toll-like receptor-dependent dendritic cell responses J. Allergy Clin. Immunol. 116 2005 185 191
13. C. Boccaccio, S. Jacod, A. Kaiser, A. Boyer, J.P. Abastado, and A. Nardin Identification of a clinical-grade maturation factor for dendritic cells J. Immunother. 25 2002 88 96
14. L.M. Bowman, and P.G. Holt Selective enhancement of systemic Th1 immunity in immunologically immature rats with an orally administered bacterial extract Infect. Immun. 69 2001 3719 3727
15. C. Braun-Fahrlander, J. Riedler, U. Herz, W. Eder, M. Waser, L. Grize, S. Maisch, D. Carr, F. Gerlach, A. Bufe, R.P. Lauener, R. Schierl, H. Renz, D. Nowak, and E. von Mutius Environmental exposure to endotoxin and its relation to asthma in school-age children N. Engl. J. Med. 347 2002 869 877
16. J.J. Cebra Influences of microbiota on intestinal immune system development Am. J. Clin. Nutr. 69 1999 1046S 1051S
17. H.R. Christensen, H. Frokiaer, and J.J. Pestka Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells J. Immunol. 168 2002 171 178
18. N.V. Contractor, H. Bassiri, T. Reya, A.Y. Park, D.C. Baumgart, M.A. Wasik, S.G. Emerson, and S.R. Carding Lymphoid hyperplasia, autoimmunity, and compromised intestinal intraepithelial lymphocyte development in colitis-free gnotobiotic IL-2-deficient mice J. Immunol. 160 1998 385 394
19. D.N. Cook, D.S. Pisetsky, and D.A. Schwartz Toll-like receptors in the pathogenesis of human disease Nat. Immunol. 5 2004 975 979
20. M.L. Cross, and H.S. Gill Can immunoregulatory lactic acid bacteria be used as dietary supplements to limit allergies? Int. Arch. Allergy Immunol. 125 2001 112 119
21. M.L. Cross, L.M. Stevenson, and H.S. Gill Anti-allergy properties of fermented foods: an important immunoregulatory mechanism of lactic acid bacteria? Int. Immunopharmacol. 1 2001 891 901
22. S. Divanovic, A. Trompette, S.F. Atabani, R. Madan, D.T. Golenbock, A. Visintin, R.W. Finberg, A. Tarakhovsky, S.N. Vogel, Y. Belkaid, E.A. Kurt-Jones, and C.L. Karp Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105 Nat. Immunol. 6 2005 571 578
23. K.J. Drachenberg, A.W. Wheeler, P. Stuebner, and F. Horak A well-tolerated grass pollen-specific allergy vaccine containing a novel adjuvant, monophosphoryl lipid A, reduces allergic symptoms after only four preseasonal injections Allergy 56 2001 498 505
24. A.L. D'Souza, C. Rajkumar, J. Cooke, and C.J. Bulpitt Probiotics in prevention of antibiotic-associated diarrhea: meta-analysis BMJ 324 2002 1361 1366
25. W. Eder, W. Klimecki, L. Yu, E. von Mutius, J. Riedler, C. Braun-Fahrlander, D. Nowak, and F.D. Martinez Toll-like receptor 2 as a major gene for asthma in children of European farmers J. Allergy Clin. Immunol. 113 2004 482 488
26. S.C. Eisenbarth, S. Cassel, and K. Bottomly Understanding asthma pathogenesis: linking innate and adaptive immunity Curr. Opin. Pediatr. 16 2004 659 666
27. K.J. Erb, J.W. Holloway, A. Sobeck, H. Moll, and G. Le Gros Infection of mice with Mycobacterium bovis-Bacillus Calmette-Guerin (BCG) suppresses allergen-induced airway eosinophilia J. Exp. Med. 187 1998 561 569
28. R.D. Fusunyan, N.N. Nanthakumar, M.E. Baldeon, and W.A. Walker Evidence for an innate immune response in the immature human intestine: toll-like receptors on fetal enterocytes Pediatr. Res. 49 2001 589 593
29. J.E. Gereda, D.Y. Leung, A. Thatayatikom, J.E. Streib, M.R. Price, M.D. Klinnert, and A.H. Liu Relation between house-dust endotoxin exposure, type 1 T-cell development, and allergen sensitisation in infants at high risk of asthma Lancet 355 2000 1680 1683
30. K. Gerhold, K. Blumchen, A. Bock, C. Seib, P. Stock, T. Kallinich, M. Lohning, U. Wahn, and E. Hamelmann Endotoxins prevent murine IgE production, T(H)2 immune responses, and development of airway eosinophilia but not airway hyperreactivity J. Allergy Clin. Immunol. 110 2002 110 116
31. K. Gerhold, K. Bluemchen, A. Franke, P. Stock, and E. Hamelmann Exposure to endotoxin and allergen in early life and its effect on allergen sensitization in mice J. Allergy Clin. Immunol. 112 2003 389 396
32. E.A. Hadley, F.I. Smillie, M.A. Turner, A. Custovic, A. Woodcock, and P.D. Arkwright Effect of Mycobacterium vaccae on cytokine responses in children with atopic dermatitis Clin. Exp. Immunol. 140 2005 101 108
33. E. Hamelmann, and U. Wahn Immune responses to allergens early in life: when and why do allergies arise? Clin. Exp. Allergy 32 2002 1679 1681
34. T. Hayashi, L. Beck, C. Rossetto, X. Gong, O. Takikawa, K. Takabayashi, D.H. Broide, D.A. Carson, and E. Raz Inhibition of experimental asthma by indoleamine 2,3-dioxygenase J. Clin. Invest. 114 2004 270 279
35. T. Helin, S. Haahtela, and T. Haahtela No effect of oral treatment with an intestinal bacterial strain, Lactobacillus rhamnosus (ATCC 53103), on birch-pollen allergy: a placebo-controlled double-blind study Allergy 57 2002 243 246
36. S.C. Higgins, E.C. Lavelle, C. McCann, B. Keogh, E. McNeela, P. Byrne, B. O'Gorman, A. Jarnicki, P. McGuirk, and K.H. Mills Toll-like receptor 4-mediated innate IL-10 activates antigen-specific regulatory T cells and confers resistance to Bordetella pertussis by inhibiting inflammatory pathology J. Immunol. 171 2003 3119 3127
37. P.G. Holt, P.D. Sly, F.D. Martinez, S.T. Weiss, B. Bjorksten, E. von Mutius, and U. Wahn Drug development strategies for asthma: in search of a new paradigm Nat. Immunol. 5 2004 695 698
38. A.A. Horner, and E. Raz Do microbes influence the pathogenesis of allergic diseases? Building the case for Toll-like receptor ligands Curr. Opin. Immunol. 15 2003 614 619
39. A.A. Horner, J.H. Van Uden, J.M. Zubeldia, D. Broide, and E. Raz DNA-based immunotherapeutics for the treatment of allergic disease Immunol. Rev. 179 2001 102 118
40. S. Illi, E. von Mutius, S. Lau, R. Bergmann, B. Niggemann, C. Sommerfeld, and U. Wahn Early childhood infectious diseases and the development of asthma up to school age: a birth cohort study BMJ 322 2001 390 395
41. E. Isolauri, T. Arvola, Y. Sutas, E. Moilanen, and S. Salminen Probiotics in the management of atopic eczema Clin. Exp. Allergy 30 2000 1604 1610
42. E. Isolauri, S. Salminen, and A.C. Ouwehand Microbial-gut interactions in health and disease Probiotics. Best. Pract. Res. Clin.Gastroenterol. 18 2004 299 313
43. C.A. Janeway Jr., and R. Medzhitov Innate immune recognition Annu. Rev. Immunol. 20 2002 197 216
44. T. Kaisho, and S. Akira Pleiotropic function of Toll-like receptors Microbes Infect. 6 2004 1388 1394
45. M. Kalliomaki, and E. Isolauri Role of intestinal flora in the development of allergy Curr. Opin. Allergy Clin. Immunol. 3 2003 15 20
46. M. Kalliomaki, S. Salminen, H. Arvilommi, P. Kero, P. Koskinen, and E. Isolauri Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial Lancet 357 2001 1076 1079
47. M. Kalliomaki, S. Salminen, T. Poussa, H. Arvilommi, and E. Isolauri Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial Lancet 361 2003 1869 1871
48. E.A. Kurt-Jones, L. Popova, L. Kwinn, L.M. Haynes, L.P. Jones, R.A. Tripp, E.E. Walsh, M.W. Freeman, D.T. Golenbock, L.J. Anderson, and R.W. Finberg Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus Nat. Immunol. 1 2000 398 401
49. R.P. Lauener, T. Birchler, J. Adamski, C. Braun-Fahrlander, A. Bufe, U. Herz, E. von Mutius, D. Nowak, J. Riedler, M. Waser, and F.H. Sennhauser Expression of CD14 and Toll-like receptor 2 in farmers' and non-farmers' children Lancet 360 2002 465 466
50. B. Lemaitre, E. Nicolas, L. Michaut, J.M. Reichhart, and J.A. Hoffmann The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults Cell 86 1996 973 983
51. A.H. Liu, and J.R. Murphy Hygiene hypothesis: fact or fiction? J. Allergy Clin. Immunol. 111 2003 471 478
52. G.B. Marks, K. Ng, J. Zhou, B.G. Toelle, W. Xuan, E.G. Belousova, and W.J. Britton The effect of neonatal BCG vaccination on atopy and asthma at age 7 to 14 years: an historical cohort study in a community with a very low prevalence of tuberculosis infection and a high prevalence of atopic disease J. Allergy Clin. Immunol. 111 2003 541 549
53. J.D. Marshall, S. Abtahi, J.J. Eiden, S. Tuck, R. Milley, F. Haycock, M.J. Reid, A. Kagey-Sobotka, P.S. Creticos, L.M. Lichtenstein, and G. Van Nest Immunostimulatory sequence DNA linked to the Amb a 1 allergen promotes T(H)1 cytokine expression while downregulating T(H)2 cytokine expression in PBMCs from human patients with ragweed allergy J. Allergy Clin. Immunol. 108 2001 191 197
54. F.D. Martinez, and P.G. Holt Role of microbial burden in aetiology of allergy and asthma Lancet 354 Suppl 2 1999 SII12 SII15
55. P.M. Matricardi, F. Rosmini, V. Panetta, L. Ferrigno, and S. Bonini Hay fever and asthma in relation to markers of infection in the United States J. Allergy Clin. Immunol. 110 2002 381 387
56. P.M. Matricardi, B. Bjorksten, S. Bonini, J. Bousquet, R. Djukanovic, S. Dreborg, J. Gereda, H.J. Malling, T. Popov, E. Raz, H. Renz, and A. Wold Microbial products in allergy prevention and therapy Allergy 58 2003 461 471
57. P. Matzinger The danger model: a renewed sense of self Science 296 2002 301 305
58. R. Medzhitov, and C.A. Janeway Jr. Decoding the patterns of self and nonself by the innate immune system Science 296 2002 298 300
59. O. Michel, J. Kips, J. Duchateau, F. Vertongen, L. Robert, H. Collet, R. Pauwels, and R. Sergysels Severity of asthma is related to endotoxin in house dust Am. J. Respir. Crit. Care Med. 154 1996 1641 1646
60. M. Miettinen, S. Matikainen, J. Vuopio-Varkila, J. Pirhonen, K. Varkila, M. Kurimoto, and I. Julkunen Lactobacilli and streptococci induce interleukin-12 (IL-12), IL-18, and gamma interferon production in human peripheral blood mononuclear cells Infect. Immun. 66 1998 6058 6062
61. K.H. Mills, and P. McGuirk Antigen-specific regulatory T cells-their induction and role in infection Semin. Immunol. 16 2004 107 117
62. M.C. Moreau Intestinal flora, probiotics and effects on the intestinal IgA immune response Arch. Pediatr. 7 Suppl 2 2000 247s 248s
63. National Asthma Education and Prevention Program. Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma. National Institutes of Health Publication No. 97-4051. Bethesda, MD, 1997. 2004.
64. M.C. Noverr, and G.B. Huffnagle Does the microbiota regulate immune responses outside the gut? Trends Microbiol. 12 2004 562 568
65. A. Poltorak, X.L. He, I. Smirnova, M.Y. Liu, C. Van Huffel, X. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, M. Freudenberg, P. Ricciardi-Castagnoli, B. Layton, and B. Beutler Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene Science 282 1998 2085 2088
66. S.L. Prescott, C. Macaubas, T. Smallacombe, B.J. Holt, P.D. Sly, and P.G. Holt Development of allergen-specific T-cell memory in atopic and normal children Lancet 353 1999 196 200
67. B. Pulendran, P. Kumar, C.W. Cutler, M. Mohamadzadeh, T. Van Dyke, and J. Banchereau Lipopolysaccharides from distinct pathogens induce different classes of immune responses in vivo J. Immunol. 167 2001 5067 5076
68. J.M. Purkerson, and P.C. Isakson Independent regulation of DNA recombination and immunoglobulin (Ig) secretion during isotype switching to IgG1 and IgE J. Exp.Med. 179 1994 1877 1883
69. D. Quarcoo, S. Weixler, R.A. Joachim, P. Stock, T. Kallinich, B. Ahrens, and E. Hamelmann Resiquimod, a new immune response modifier from the family of imidazoquinolinamines, inhibits allergen-induced Th2 responses, airway inflammation and airway hyper-reactivity in mice Clin. Exp. Allergy 34 2004 1314 1320
70. S. Rautava, M. Kalliomaki, and E. Isolauri New therapeutic strategy for combating the increasing burden of allergic disease: probiotics-A Nutrition, Allergy, Mucosal Immunology and Intestinal Microbiota (NAMI) Research Group report J. Allergy Clin. Immunol. 116 2005 31 37
71. V. Redecke, H. Hacker, S.K. Datta, A. Fermin, P.M. Pitha, D.H. Broide, and E. Raz Cutting edge: activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma J. Immunol. 172 2004 2739 2743
72. M. Schnare, G.M. Barton, A.C. Holt, K. Takeda, S. Akira, and R. Medzhitov Toll-like receptors control activation of adaptive immune responses Nat. Immunol. 2 2001 947 950
73. T. Shirakawa, T. Enomoto, S. Shimazu, and J.M. Hopkin The inverse association between tuberculin responses and atopic disorder Science 275 1997 77 79
74. P.M. Shirtcliffe, S.E. Easthope, S. Cheng, M. Weatherall, P.L. Tan, G. Le Gros, and R. Beasley The effect of delipidated deglycolipidated (DDMV) and heat-killed Mycobacterium vaccae in asthma Am. J. Respir. Crit. Care Med. 163 2001 1410 1414
75. P.M. Shirtcliffe, S.E. Easthope, M. Weatherall, and R. Beasley Effect of repeated intradermal injections of heat-inactivated Mycobacterium bovis bacillus Calmette-Guerin in adult asthma Clin. Exp. Allergy 34 2004 207 212
76. R. Spisek, J. Brazova, D. Rozkova, K. Zapletalova, A. Sediva, and J. Bartunkova Maturation of dendritic cells by bacterial immunomodulators Vaccine 22 2004 2761 2768
77. L.C. Stene, and P. Nafstad Relation between occurrence of type 1 diabetes and asthma Lancet 357 2001 607 608
78. C. Steurer-Stey, L.M. Bachmann, J. Steurer, and M.R. Tramer Oral purified bacterial extracts in chronic bronchitis and COPD: systematic review Chest 126 2004 1645 1655
79. D.P. Strachan Hay fever, hygiene, and household size BMJ 299 1989 1259 1260
80. N. Sudo, S. Sawamura, K. Tanaka, Y. Aiba, C. Kubo, and Y. Koga The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction J. Immunol. 159 1997 1739 1745
81. N. Sudo, X.N. Yu, Y. Aiba, N. Oyama, J. Sonoda, Y. Koga, and C. Kubo An oral introduction of intestinal bacteria prevents the development of a long-term Th2-skewed immunological memory induced by neonatal antibiotic treatment in mice Clin. Exp. Allergy 32 2002 1112 1116
82. K. Takeda, T. Kaisho, and S. Akira Toll-like receptors Annu. Rev. Immunol. 21 2003 335 376
83. H. Tighe, K. Takabayashi, D. Schwartz, G. Van Nest, S. Tuck, J.J. Eiden, A. Kagey-Sobotka, P.S. Creticos, L.M. Lichtenstein, H.L. Spiegelberg, and E. Raz Conjugation of immunostimulatory DNA to the short ragweed allergen amb a 1 enhances its immunogenicity and reduces its allergenicity J. Allergy Clin. Immunol. 106 2000 124 134
84. J.A. Vanderhoof, and R.J. Young Current and potential uses of probiotics Ann. Allergy, Asthma, & Immun. 93 2004 S33 S37
85. M.H. Vargas, D.A. Bernal-Alcantara, M.A. Vaca, F. Franco-Marina, and R. Lascurain Effect of BCG vaccination in asthmatic schoolchildren Pediatr. Allergy Immunol. 15 2004 415 420
86. G. Velasco, M. Campo, O.J. Manrique, A. Bellou, H. He, R.S. Arestides, B. Schaub, D.L. Perkins, and P.W. Finn Toll-like receptor 4 or 2 agonists decrease allergic inflammation Am. J. Respir. Cell Mol. Biol. 32 2005 218 224
87. M. Viljanen, E. Savilahti, T. Haahtela, K. Juntunen-Backman, R. Korpela, T. Poussa, T. Tuure, and M. Kuitunen Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial Allergy 60 2005 494 500
88. L.C. von Hertzen, and T. Haahtela Could the risk of asthma and atopy be reduced by a vaccine that induces a strong T-helper type 1 response?"" Am J. Respir. Cell Mol. Biol. 22 2000 139 142
89. L. von Hertzen, T. Klaukka, H. Mattila, and T. Haahtela Mycobacterium tuberculosis infection and the subsequent development of asthma and allergic conditions J. Allergy Clin. Immunol. 104 1999 1211 1214
90. E. von Mutius, S. Illi, T. Hirsch, W. Leupold, U. Keil, and S.K. Weiland Frequency of infections and risk of asthma, atopy and airway hyperresponsiveness in children Eur. Respir. J. 14 1999 4 11
91. E. von Mutius, N. Pearce, R. Beasley, S. Cheng, O. von Ehrenstein, B. Bjorksten, and S. Weiland International patterns of tuberculosis and the prevalence of symptoms of asthma, rhinitis, and eczema Thorax 55 2000 449 453
92. C. Walker, E. Sawicka, and G.A. Rook Immunotherapy with mycobacteria Curr. Opin. Allergy Clin. Immunol. 3 2003 481 486
93. J.G. Wheeler, M.L. Bogle, S.J. Shema, M.A. Shirrell, K.C. Stine, A.J. Pittler, A.W. Burks, and R.M. Helm Impact of dietary yogurt on immune function Am. J. Med. Sci. 313 1997 120 123
94. M. Wills-Karp, J. Santeliz, and C.L. Karp The germless theory of allergic disease: revisiting the hygiene hypothesis Nat. Rev. Immunol. 1 2001 69 75
95. J.E. Wooldridge, and G.J. Weiner CpG DNA and cancer immunotherapy: orchestrating the antitumor immune response Curr. Opin. Oncol. 15 2003 440 445
96. M. Yazdanbakhsh, P.G. Kremsner, and R. van Ree Allergy, parasites, and the hygiene hypothesis Science 296 2002 490 494
97. C. Zuany-Amorim, J. Hastewell, and C. Walker Toll-like receptors as potential therapeutic targets for multiple diseases Nat. Rev. Drug Discov. 1 2002 797 807
98. C. Zuany-Amorim, E. Sawicka, C. Manlius, A. Le Moine, L.R. Brunet, D.M. Kemeny, G. Bowen, G. Rook, and C. Walker Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells Nat. Med. 8 2002 625 629